Navigation Links
Varian Medical Systems to Introduce Two New PaxScan(R) Flat-Panel Digital Radiography Products at RSNA This Year
Date:11/21/2007

PALO ALTO, Calif., Nov. 21 /PRNewswire-FirstCall/ -- Varian Medical Systems, Inc. (NYSE: VAR), a premier supplier of X-ray tubes and the PaxScan(R) line of digital X-ray image detectors, will introduce two new PaxScan products at the annual meeting of the Radiological Society of North America (RSNA) at McCormick Place in Chicago from November 25 - 30, 2007.

-- The PaxScan 4336R adds a 14 x 17 inch detector to Varian's broad line

of flat panel products. It is specifically designed to replace a

standard film cassette for use in radiographic applications.

-- The PaxScan 4343R is Varian's largest flat-panel X-ray image detector.

At 17 x 17 inches, it is designed for permanent mounting in

radiographic tables or wall stands, or for any application that

requires a large field of view.

Except for their physical size, both panels incorporate identical detector arrays and readout electronics, making them excellent radiographic imaging solutions for any general purpose room. Image data and control signals, which are based upon an industry standard Gigabit Ethernet interface, can be passed to and from these detectors using standard network interface cards. Images are transmitted instantaneously to the image processor for display and diagnosis. Housings and cable attachments are designed for simple integration into any diagnostic imaging system.

Both of these panels come bundled with VIVA(TM) software, a system design and development application for image acquisition and viewing on a workstation running Microsoft(R) Windows(TM). This software package provides an easy way for the original equipment manufacturer or system integrator to begin image analysis and system design quickly. Also included with VIVA is a complete Dynamic Link Library (DLL) to facilitate simple software development. Sample code is provided to ease the design of detector set-up and calibration, image acquisition, and image optimization. All Varian X-ray products come with excellent applications support to help customers with system design and development.

In addition to these new products, Varian will exhibit the company's full line of X-ray tubes, as well as the company's cancer treatment technologies, including the market-leading Eclipse(TM) radiotherapy treatment planning system for planning and adapting conformal radiation therapy treatments on the basis of 3-D image data.

High resolution images of these and other Varian products are available in the company's online newsroom at: http://varian.mediaroom.com/index.php?s=media_library.

ABOUT VARIAN MEDICAL SYSTEMS

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 4,500 people who are located at manufacturing sites in North America and Europe and approximately 60 sales and support offices around the world. For more information, visit http://www.varian.com/.

FOR INFORMATION CONTACT:

Meryl Ginsberg, (650) 424-6444

meryl.ginsberg@varian.com


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Cranberry Could Juice Up Ovarian Cancer Treatment
2. New Ovarian Cancer Drug Trial Under Way
3. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
4. Pelvic Exams Can Help Spot Ovarian Cancer
5. Study fuels debate over whether exercise and body size influence ovarian cancer risk
6. Experimental drug boosts survival in recurrent ovarian cancer
7. New Ovarian Cancer Biomarker Research Act Introduced
8. Common Early-Warning Symptoms of Ovarian Cancer Identified in CDC/Thomson Healthcare Study
9. More Fiber, Less Fat Help Prevent Ovarian Cancer
10. Media availability: low-fat dietary pattern may lower risk of ovarian cancer
11. The Silent Killer, Ovarian Cancer on Your Cancer Today (TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop ... The fitness app plans to fix the two major problems leading the fitness industry today:, ... all type program , They don’t eliminate all the reasons people quit their ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: